ITEK Balance Sheet Health

Financial Health criteria checks 5/6

ITEK has a total shareholder equity of ₩159.0B and total debt of ₩39.4B, which brings its debt-to-equity ratio to 24.7%. Its total assets and total liabilities are ₩231.0B and ₩72.0B respectively. ITEK's EBIT is ₩1.3B making its interest coverage ratio 1.5. It has cash and short-term investments of ₩104.0B.

Key information

24.7%

Debt to equity ratio

₩39.36b

Debt

Interest coverage ratio1.5x
Cash₩104.03b
Equity₩159.04b
Total liabilities₩71.97b
Total assets₩231.00b

Recent financial health updates

Recent updates

Subdued Growth No Barrier To ITEK, Inc.'s (KOSDAQ:119830) Price

Dec 13
Subdued Growth No Barrier To ITEK, Inc.'s (KOSDAQ:119830) Price

Some Investors May Be Willing To Look Past ITEK's (KOSDAQ:119830) Soft Earnings

Aug 17
Some Investors May Be Willing To Look Past ITEK's (KOSDAQ:119830) Soft Earnings

Is ITEK (KOSDAQ:119830) Weighed On By Its Debt Load?

Mar 13
Is ITEK (KOSDAQ:119830) Weighed On By Its Debt Load?

ITEK (KOSDAQ:119830) Has A Pretty Healthy Balance Sheet

May 10
ITEK (KOSDAQ:119830) Has A Pretty Healthy Balance Sheet

ITEK (KOSDAQ:119830) Is Reinvesting At Lower Rates Of Return

Mar 29
ITEK (KOSDAQ:119830) Is Reinvesting At Lower Rates Of Return

Should ITEK (KOSDAQ:119830) Be Disappointed With Their 59% Profit?

Feb 09
Should ITEK (KOSDAQ:119830) Be Disappointed With Their 59% Profit?

Financial Position Analysis

Short Term Liabilities: A119830's short term assets (₩127.8B) exceed its short term liabilities (₩63.0B).

Long Term Liabilities: A119830's short term assets (₩127.8B) exceed its long term liabilities (₩9.0B).


Debt to Equity History and Analysis

Debt Level: A119830 has more cash than its total debt.

Reducing Debt: A119830's debt to equity ratio has reduced from 85.1% to 24.7% over the past 5 years.

Debt Coverage: A119830's debt is well covered by operating cash flow (25.9%).

Interest Coverage: A119830's interest payments on its debt are not well covered by EBIT (1.5x coverage).


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/31 05:59
End of Day Share Price 2025/01/31 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ITEK, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution